Substance use during the COVID-19 pandemic among persons with traumatic spinal cord injury: A cross-sectional perspective
The pandemic may have been associated with increased use of non-prescribed substances in the traumatic spinal cord injury population. Efforts to pursue longitudinal investigations would be warranted for definitive analysis of trends. The provision of demonstrably effective substance use treatment resources delivered via accessible methods will likely be needed in this population, particularly opioid treatment.
Authors
- Huacong Wen (ORCID: https://orcid.org/0000-0002-7343-2627)
- Amanda Botticello (ORCID: https://orcid.org/0000-0002-7227-3249)
- Anne Deutsch (ORCID: https://orcid.org/0000-0003-2290-7757)
- Yuying Chen (ORCID: https://orcid.org/0009-0007-2192-6485)
- J. S. Richards
- James G. Lo
Institutions
- Rutgers, The State University of New Jersey (US)
- Northwestern University (US)
- Shirley Ryan AbilityLab (US)
- RTI International (US)
- Kessler Foundation (US)
- Foundation Center (US)
- University of Alabama at Birmingham (US)
- Center for Assessment (US)
- Rutgers New Jersey Medical School (US)
- HealthPartners (US)
Publication Details
- Journal
- Journal of Spinal Cord Medicine
- Published
- 2024-10-11
- DOI
- https://doi.org/10.1080/10790268.2024.2400748
- Primary Topic
- Spinal Cord Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Alabama at Birmingham
- Department of Health and Human Services, State Government of Victoria
- Administration for Community Living
- National Institute on Disability, Independent Living, and Rehabilitation Research